Lido Advisors, LLC Astrazeneca PLC Transaction History
Lido Advisors, LLC
- $20.3 Billion
- Q3 2024
A detailed history of Lido Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lido Advisors, LLC holds 28,148 shares of AZN stock, worth $1.81 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,148
Previous 20,075
40.21%
Holding current value
$1.81 Million
Previous $1.57 Million
40.13%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.05 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.71 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.4 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.37 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.23 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...